Edition:
United States

Lennox International Inc (LII)

LII on New York Consolidated

205.74USD
16 Feb 2018
Change (% chg)

$-1.49 (-0.72%)
Prev Close
$207.23
Open
$206.88
Day's High
$211.87
Day's Low
$203.47
Volume
396,874
Avg. Vol
313,387
52-wk High
$223.05
52-wk Low
$159.57

Chart for

About

Lennox International Inc. is a provider of climate control solutions. The Company designs, manufactures and markets a range of products for the heating, ventilation, air conditioning and refrigeration (HVACR) markets. It operates through three segments: Residential Heating & Cooling; Commercial Heating & Cooling, and Refrigerati... (more)

Overall

Beta: 1.20
Market Cap(Mil.): $8,594.55
Shares Outstanding(Mil.): 41.77
Dividend: 0.51
Yield (%): 0.98

Financials

  Industry Sector
P/E (TTM): -- 27.47 17.27
EPS (TTM): -- -- --
ROI: -- 11.04 35.43
ROE: -- 13.16 17.10

BRIEF-Lennox International Q4 EPS $1.02 From Continuing Operations

* LENNOX INTERNATIONAL REPORTS RECORD FOURTH QUARTER MARGIN AND PROFIT TO CAP RECORD YEAR AND RAISES 2018 EPS GUIDANCE FOR U.S. TAX LEGISLATION

Feb 06 2018

BRIEF-Ovid Therapeutics Announces TAK-935/OV935 Granted Orphan Drug Designation By U.S. FDA For Treatment Of Lennox-Gastaut Syndrome

* OVID THERAPEUTICS ANNOUNCES TAK-935/OV935 GRANTED ORPHAN DRUG DESIGNATION BY U.S. FDA FOR TREATMENT OF LENNOX-GASTAUT SYNDROME

Dec 20 2017

BRIEF-Lennox International Sees Fy18 Revenue Up 3 To 7 Percent

* REAFFIRMS FY 2017 ADJUSTED EARNINGS PER SHARE VIEW $7.75 TO $8.05 FROM CONTINUING OPERATIONS

Dec 13 2017

BRIEF-Lennox International says Lpac, co entered into amendment to amended, restated receivables purchase agreement initially dated Nov 18, 2011

* Lennox International - ‍as of Nov 13, Lennox, Lpac, co entered into amendment to amended, restated receivables purchase agreement initially dated nov 18, 2011

Nov 16 2017

Earnings vs. Estimates